Abstract
Normalized ctTHb levels measured prior to neoadjuvant chemotherapy can predict breast cancer response to NAC and potentially be used to improve personalized therapeutic strategies for HER-2 positive tumors.
© 2020 The Author(s)
PDF Article | Presentation VideoMore Like This
Quing Zhu, Susan Tannenbaum, Scott H. Kurtzman, Patricia DeFusco, Andrew Ricci, Hamed Vavadi, Feifei Zhou, Chen Xu, Alex Merkulov, Poornima Hegde, Mark Kane, Liqun Wang, and Kert Sabbath
OTh4D.2 Optical Tomography and Spectroscopy (OT&S) 2018
Amir Y. Sajjadi, Steven J. Isakoff, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Stefan A. Carp
BW4B.5 Biomedical Optics (BIOMED) 2014
Quing Zhu, Steve Poplack, Foluso Ademuyiwa, and Catherine Young
SW4D.6 Optical Tomography and Spectroscopy (OT&S) 2020